Annual Operating Expenses
$274.40 M
+$114.14 M+71.22%
December 31, 2023
Summary
- As of February 20, 2025, IRWD annual total operating expenses is $274.40 million, with the most recent change of +$114.14 million (+71.22%) on December 31, 2023.
- During the last 3 years, IRWD annual operating expenses has risen by +$46.33 million (+20.32%).
- IRWD annual operating expenses is now -16.56% below its all-time high of $328.85 million, reached on December 31, 2018.
Performance
IRWD Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$65.94 M
-$1.41 M-2.10%
September 30, 2024
Summary
- As of February 20, 2025, IRWD quarterly total operating expenses is $65.94 million, with the most recent change of -$1.41 million (-2.10%) on September 30, 2024.
- Over the past year, IRWD quarterly operating expenses has stayed the same.
- IRWD quarterly operating expenses is now -34.54% below its all-time high of $100.74 million, reached on September 30, 2017.
Performance
IRWD Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
IRWD Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +71.2% | 0.0% |
| 3 y3 years | +20.3% | +8.9% |
| 5 y5 years | -16.6% | +8.9% |
IRWD Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +71.2% | -24.3% | +69.8% |
| 5 y | 5-year | -4.5% | +71.2% | -24.3% | +70.6% |
| alltime | all time | -16.6% | +303.1% | -34.5% | +202.8% |
Ironwood Pharmaceuticals Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $65.94 M(-2.1%) |
| Jun 2024 | - | $67.35 M(+6.2%) |
| Mar 2024 | - | $63.42 M(-14.7%) |
| Dec 2023 | $274.40 M(+71.2%) | $74.34 M(+7.7%) |
| Sep 2023 | - | $69.03 M(-20.7%) |
| Jun 2023 | - | $87.06 M(+98.0%) |
| Mar 2023 | - | $43.96 M(+13.2%) |
| Dec 2022 | $160.26 M(-11.7%) | $38.84 M(-3.3%) |
| Sep 2022 | - | $40.16 M(-3.4%) |
| Jun 2022 | - | $41.58 M(+4.8%) |
| Mar 2022 | - | $39.68 M(-34.4%) |
| Dec 2021 | $181.54 M(-20.4%) | $60.54 M(+56.6%) |
| Sep 2021 | - | $38.65 M(-1.4%) |
| Jun 2021 | - | $39.22 M(-9.1%) |
| Mar 2021 | - | $43.14 M(-14.2%) |
| Dec 2020 | $228.06 M(-20.7%) | $50.25 M(-11.3%) |
| Sep 2020 | - | $56.62 M(-0.2%) |
| Jun 2020 | - | $56.72 M(-12.0%) |
| Mar 2020 | - | $64.48 M(-1.9%) |
| Dec 2019 | $287.49 M(-12.6%) | $65.73 M(-4.0%) |
| Sep 2019 | - | $68.47 M(-4.9%) |
| Jun 2019 | - | $72.00 M(-11.4%) |
| Mar 2019 | - | $81.29 M(+3.3%) |
| Dec 2018 | $328.85 M(+1.0%) | $78.66 M(-2.7%) |
| Sep 2018 | - | $80.85 M(-6.5%) |
| Jun 2018 | - | $86.43 M(-13.1%) |
| Mar 2018 | - | $99.48 M(+151.7%) |
| Dec 2017 | $325.54 M(+3.8%) | $39.52 M(-60.8%) |
| Sep 2017 | - | $100.74 M(+5.4%) |
| Jun 2017 | - | $95.56 M(+6.5%) |
| Mar 2017 | - | $89.73 M(-0.7%) |
| Dec 2016 | $313.75 M | $90.35 M(+5.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2016 | - | $85.73 M(+23.1%) |
| Jun 2016 | - | $69.67 M(+2.4%) |
| Mar 2016 | - | $68.01 M(+15.0%) |
| Dec 2015 | $233.99 M(+6.3%) | $59.13 M(+5.1%) |
| Sep 2015 | - | $56.27 M(-8.7%) |
| Jun 2015 | - | $61.60 M(+8.1%) |
| Mar 2015 | - | $56.99 M(-1.8%) |
| Dec 2014 | $220.22 M(-17.7%) | $58.06 M(+8.2%) |
| Sep 2014 | - | $53.66 M(+4.3%) |
| Jun 2014 | - | $51.44 M(-9.9%) |
| Mar 2014 | - | $57.07 M(+11.4%) |
| Dec 2013 | $267.68 M(+20.6%) | $51.24 M(-13.8%) |
| Sep 2013 | - | $59.46 M(-10.1%) |
| Jun 2013 | - | $66.13 M(-27.2%) |
| Mar 2013 | - | $90.86 M(+30.0%) |
| Dec 2012 | $222.04 M(+68.2%) | $69.92 M(+43.3%) |
| Sep 2012 | - | $48.80 M(-12.0%) |
| Jun 2012 | - | $55.44 M(+15.8%) |
| Mar 2012 | - | $47.88 M(+22.2%) |
| Dec 2011 | $132.01 M(+26.2%) | $39.19 M(+15.8%) |
| Sep 2011 | - | $33.83 M(+12.0%) |
| Jun 2011 | - | $30.21 M(+5.0%) |
| Mar 2011 | - | $28.78 M(-2.7%) |
| Dec 2010 | $104.62 M(+10.0%) | $29.57 M(+17.2%) |
| Sep 2010 | - | $25.22 M(-4.8%) |
| Jun 2010 | - | $26.50 M(+13.6%) |
| Mar 2010 | - | $23.33 M(-21.6%) |
| Dec 2009 | $95.14 M(+21.8%) | $29.77 M(+26.4%) |
| Sep 2009 | - | $23.54 M(-6.5%) |
| Jun 2009 | - | $25.19 M(+5.8%) |
| Mar 2009 | - | $23.80 M(+9.3%) |
| Dec 2008 | $78.14 M(+14.8%) | $21.77 M |
| Dec 2007 | $68.08 M | - |
FAQ
- What is Ironwood Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for Ironwood Pharmaceuticals?
- What is Ironwood Pharmaceuticals annual operating expenses year-on-year change?
- What is Ironwood Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Ironwood Pharmaceuticals?
- What is Ironwood Pharmaceuticals quarterly operating expenses year-on-year change?
What is Ironwood Pharmaceuticals annual total operating expenses?
The current annual operating expenses of IRWD is $274.40 M
What is the all time high annual operating expenses for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals all-time high annual total operating expenses is $328.85 M
What is Ironwood Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, IRWD annual total operating expenses has changed by +$114.14 M (+71.22%)
What is Ironwood Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of IRWD is $65.94 M
What is the all time high quarterly operating expenses for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals all-time high quarterly total operating expenses is $100.74 M
What is Ironwood Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, IRWD quarterly total operating expenses has changed by $0.00 (0.00%)